Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Jun. 30, 2012	Jul. 02, 2011
Operating activities:
Net income	$ 3,693,420	$ 2,789,447
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	899,775	603,399
Provision for losses on accounts receivable	(27,000)	53,202
Increase in cash value of life insurance	(148,302)	(109,281)
Deferred compensation	(40,503)	(38,476)
Stock compensation expense	54,198	51,431
Changes in operating assets and liabilities:
Accounts receivable	(967,016)	(27,348)
Inventories	2,241,060	(627,151)
Prepaid expenses and other assets	288,275	282,021
Accounts payable and accrued expenses	(395,736)	(173,553)
Net cash provided by operating activities	5,598,171	2,803,691
Investing activities:
Acquisition of M.C. Healthcare	(8,251,831)
Purchases of marketable securities		(2,760,000)
Proceeds from sale of securities available for sale	4,000,000	1,060,000
Purchases of property and equipment	(627,645)	(171,183)
Payments for other assets	(88,917)	(66,317)
Net cash used for investing activities	(4,968,393)	(1,937,500)
Financing activities:
Proceeds of long-term debt	9,300,000
Repayment of long-term debt	(8,300,000)
Dividends paid	(993,518)	(859,393)
Purchase and retirement of common stock		(8,292)
Common stock issued upon exercise of options	68,946	114,790
Net cash provided by/used for financing activities	75,428	(752,895)
Effect of exchange rates on cash	(40,212)
Increase in cash and cash equivalents	664,994	113,296
Cash and cash equivalents at beginning of period	2,124,406	781,195
Cash and cash equivalents at end of period	$ 2,789,400	$ 894,491